Extra doses of COVID-19 vaccine approved
The European Medicines Agency (EMA) has confirmed that health authorities can extract six doses of vaccine from each vial of Comirnaty, a vaccine against COVID-19 manufactured by Pfizer/BioNTech.
The European Medicines Agency (EMA) has confirmed that health authorities can extract six doses of vaccine from each vial of Comirnaty, a vaccine against COVID-19 manufactured by Pfizer/BioNTech.
Cybercriminals hacked into the European Medicine Agency (EMA) in December to steal key files related to COVID-19 vaccines, the agency has confirmed.
We live in a world invaded by plastic. Its role as a chemically stable, versatile and multi-purpose fostered its massive use, which has finally translated into our current… read more.
Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases… read more.
Interview and article by Chrstine Clark The findings of a recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) could have important implications… read more.
Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr… read more.
Interview and article by Christine Clark. Rheumatoid arthritis (RA) affects about one percent of the population in the UK and comorbidities are reported to be common. A recent… read more.
Attention Deficit Hyperactive Disorder (ADHD) can have negative consequences on mental health into adulthood.
Article written by Bruce Sylvester Among persons with prediabetes, a lifestyle intervention can almost halve the risk of developing Type 2 diabetes, researchers from a large, new study… read more.
Article written by Bruce Sylvester Investigators from the QUAZAR trial report that treatment with oral azacytidine (CC-486), significantly improves survival in older patients, over age of 55, with… read more.
Article written by Bruce Sylvester The diabetes drug canagliflozin, which has already shown efficacy in slowing kidney disease, is also effective among patients with advanced kidney disease.
Article written by Bruce Sylvester. Rilonacept, an FDA approved drug for other inflammatory diseases, shows high efficacy for treating acute pericarditis, an inflammation of tissue around the heart.